文献速递甲状腺与颈部外科围术期管理与 ERAS

经胸乳入路腔镜甲状腺切除术治疗分化型甲状腺癌能否达到与开放手术相似的治疗效果?

Treatment of differentiated thyroid cancer: can endoscopic thyroidectomy via a chest-breast approach achieve similar therapeutic effects as open surgery?
PubMed 文献 · Surg Endosc · 2018-05-14

结果显示两组在手术范围、淋巴结清扫数目、放射性碘摄取、甲状腺球蛋白水平及并发症等方面均无显著差异,结论认为经胸乳入路腔镜全甲状腺切除加中央区淋巴结清扫安全有效,训练有素的外科医生对选定患者可达到与开放手术相似的治疗效果。

要点

  • 经胸乳入路腔镜甲状腺切除术与开放手术治疗分化型甲状腺癌的总体并发症无显著差异。
  • 两组在手术范围、淋巴结清扫数目及术后放射性碘相关特殊指标上均无显著差异。
  • 腔镜组年龄和体重指数低于开放组,患者选择可能影响结果解读。

核心结论

  • 经胸乳入路腔镜全甲状腺切除加中央区淋巴结清扫安全有效,对选定分化型甲状腺癌患者可达到与开放手术相似的治疗效果。

主要发现

  • 两组性别(P=0.120)、术后住院时间(P=0.766)、手术时间(P=0.065)、术中出血量(P=0.064)、肿瘤直径(P=0.059)及总体并发症(P=0.828)均无显著差异。
  • 暂时性甲状旁腺功能减退(P=0.771)、暂时性喉返神经损伤(P=0.474)及严重颈部皮肤牵拉感(2.5 vs. 0%,P=1.000)两组间无显著差异。
  • 腔镜组年龄和体重指数低于开放组(P<0.05)。
  • 手术范围(P=0.872)、放射性碘摄取2h/24h(P=0.660/P=0.955)、放射性锝摄取(P=0.116)、清扫淋巴结数目(P=0.157)、放射性碘治疗前甲状腺球蛋白(P=0.188)及治疗后甲状腺球蛋白(P=0.159)两组间无显著差异。
  • 甲状腺残留区放射性核素显像不同时间点(99mTc 15min:P=0.144;131I 24h:P=0.243;131I 72h:P=0.624)及可疑淋巴结转移放射性核素显像(无:P=0.805;中央区:P=0.744;侧颈:P=1.000;中央区+侧颈:P=0.958)两组间无显著差异。

临床怎么用

  • 对选定分化型甲状腺癌患者,训练有素的外科医生可采用经胸乳入路腔镜全甲状腺切除加中央区淋巴结清扫,以达到与开放手术相似的治疗效果。

局限性

  • 本研究为回顾性设计,样本量较小(共76例),腔镜组年龄和体重指数低于开放组,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: An analysis of some special factors was performed to further evaluate and discuss whether endoscopic surgery and traditional open surgery have similar therapeutic outcomes for differentiated thyroid cancer (DTC). METHODS: A retrospective study was performed on 76 patients undergoing surgery to treat DTC. Forty patients were treated by endoscopic thyroidectomy via the chest-breast approach (endoscopic group) and thirty-six patients were treated by open surgery (open group). Serum thyroglobulin (sTg), radioactive iodine uptake (RAIU), radioactive technetium uptake (RATU), radionuclide imaging of the thyroid residual area (RITRA), radionuclide imaging of suspicious lymph nodes metastasis (RISLNM), and other general indexes were analyzed and compared between the two groups. RESULTS: All surgeries were successfully completed in both groups. There were no significant differences between the two groups regarding gender (P = 0.120), postoperative hospital stay (P = 0.766), operation time (P = 0.065), intra-operative blood loss (P = 0.064), tumor diameter (P = 0.059), and overall complications (P = 0.828). Among these complications, there was no significant difference between the two approaches in transient hypoparathryoidism (P = 0.771), transient recurrent laryngeal injury (P = 0.474) and serious neck skin traction sensation (2.5 vs. 0%, P = 1.000). Age and body mass index were lower in the endoscopic group than the open group (P < 0.05). No significant difference was found in special factors between two groups concerning surgical range (P = 0.872), RAIU-2 h/24 h (P = 0.660/P = 0.955), RATU (P = 0.116), number of dissected lymph nodes (P = 0.157), sTg before radioiodine therapy (P = 0.188), sTg after radioiodine therapy (P = 0.159), RITRA at different time points (99mTc 15 min: P = 0.144; 131I 24 h: P = 0.243; 131I 72 h: P = 0.624) and RISLNM (none: P = 0.805; central: P = 0.744; lateral: P = 1.000; central + lateral: P = 0.958). CONCLUSION: Endoscopic total thyroidectomy and central lymph nodes dissection via a chest-breast approach are safe and effective. Through the detection of the postoperative special factors, a well-trained surgeon can achieve similar therapeutic results for selected patients with DTC, compared with open surgery.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Qu R, Li J, Yang J, et al. Treatment of differentiated thyroid cancer: can endoscopic thyroidectomy via a chest-breast approach achieve similar therapeutic effects as open surgery? Surg Endosc. 2018. PMID: 29761277. doi:10.1007/s00464-018-6221-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。